Back
Apellis Pharmaceuticals Vs. Dave Industry Stock Comparison
Sell
44
APLS
Apellis Pharmaceuticals
Last Price:
28.71
Seasonality Move:
20.78%
Buy
99
DAVE
Dave
Last Price:
81.75
Seasonality Move:
82.07%
Sell
44
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $28.23. The Score for APLS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
99
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $90.46. The Score for DAVE is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $28.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 46.19 | Sell |
Chaikin Money Flow: | -1450356 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.99 - 28.75) | Buy |
Bollinger Bands (100): | (29.38 - 39.28) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.7 | Buy |
Relative Strength Index (14 RSI): | 89.82 | Buy |
Chaikin Money Flow: | 1682432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.65 - 56.79) | Buy |
Bollinger Bands (100): | (31.2 - 46.26) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.91 | Sell |
20-day SMA: | 28.03 | Buy |
50-day SMA: | 30.65 | Sell |
200-day SMA: | 43.67 | Sell |
8-day EMA: | 28.77 | Sell |
20-day EMA: | 28.57 | Sell |
50-day EMA: | 30.49 | Sell |
200-day EMA: | 40.29 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.07 | Buy |
20-day SMA: | 46.26 | Buy |
50-day SMA: | 42.24 | Buy |
200-day SMA: | 37.25 | Buy |
8-day EMA: | 59.69 | Buy |
20-day EMA: | 49.96 | Buy |
50-day EMA: | 44.12 | Buy |
200-day EMA: | 35.62 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.36 per share.
Apellis Pharmaceuticals Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |